Jeffrey VanDeusen - Concepedia

Author

Jeffrey VanDeusen

Also Known As

J VanDeusen, J. B. VanDeusen, J.B. VanDeusen, Jeff Vandeusen, Jeffery Vandeusen, Jeffrey B VanDeusen, Jeffrey B Vandeusen, Jeffrey B. VanDeusen, Jeffrey B. Vandeusen, Jeffrey Bryan VanDeusen

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

The Ohio State University The Ohio State University Wexner Medical Center Cancer Genetics (United States)The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Institute for Behavioral Medicine

About

Jeffrey VanDeusen is an author at The Ohio State University specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1.8K
2	Allergy	2	2	670
3	Engineering	1	1	29
4	Health Sciences	1	1	16
5	Social Sciences	1	1	39

Jeffrey VanDeusen

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Differential Cytokine and Chemokine Gene Expression by Human NK Cells Following Activation with IL-18 or IL-15 in Combination with IL-12: Implications for the Innate Immune Response Todd A. Fehniger, Manisha H. Shah, Matthew J. Turner, The Journal of Immunology Secrete CytokinesInnate Immune SystemImmunologyImmune RegulationNk Cells	1999	639
In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells Megan A. Cooper, Jennifer E. Bush, Todd A. Fehniger, Blood	2002	439
Fatal Leukemia in Interleukin 15 Transgenic Mice Follows Early Expansions in Natural Killer and Memory Phenotype Cd8+ T Cells Todd A. Fehniger, Kazuhiro Suzuki, Anand Ponnappan, The Journal of Experimental Medicine Interleukin 15Cancer ImmunosurveillanceLymphocyte DevelopmentMedicineImmunology	2001	365
Antihelminth Compound Niclosamide Downregulates Wnt Signaling and Elicits Antitumor Responses in Tumors with Activating APC Mutations Takuya Osada, Minyong Chen, Xiao Yang, Cancer Research ImmunologyPathologyCrc CellsCancer BiologyAdenomatous Polyposis Coli	2011	262
Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia Li‐Rong Yu, Jeffrey VanDeusen, Brian Becknell, Nature Genetics ChromatinCancer Identifies Id4Epigenetic ChangeGeneticsEpigenomics	2005	166
Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy Todd A. Fehniger, Eric M. Bluman, Michelle M. Porter, Journal of Clinical Investigation	2000	100
In Vivo Role of Flt3 Ligand and Dendritic Cells in NK Cell Homeostasis Martin Guimond, Aharon G. Freud, Hsiaoyin Mao, The Journal of Immunology Nk Cell HomeostasisImmunologyImmunologic MechanismImmune SystemImmunotherapy	2010	65
Progression-Free Survival for Real-World Use of Palbociclib in Hormone Receptor-Positive Metastatic Breast Cancer Jonathan Wilkie, M. Alexandra Schickli, Michael Berger, Clinical Breast Cancer Progression-free SurvivalBreast OncologyOncologyMedicineReal-world Use	2019	46
Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors Allison Quick, Filadelfiya Zvinovski, Catherine O. Hudson, Supportive Care in Cancer Laser ScienceMedicineLaser ApplicationsGynecologyBreast Cancer Survivors	2019	43
Worry and rumination in breast cancer patients: perseveration worsens self-rated health Megan E. Renna, M. Rosie Shrout, Annelise A. Madison, Journal of Behavioral Medicine Psychological Co-morbiditiesBehavioral MedicineCancer LiteracyPsychiatryBreast Cancer Patients	2020	39

Page 1